Peer reviewed
Ipamorelin, the First Selective Growth Hormone Secretagogue: Pharmacology
Raun et al. (1998) original pharmacology publication (PMID 9860070) describing ipamorelin as a pentapeptide growth hormone secretagogue with selectivity for GH release over cortisol and prolactin in animal models.
European Journal of Endocrinology (PubMed)Published 1998-12-01Accessed 2026-07-01
Registry record
Source metadata
- Publisher
- European Journal of Endocrinology (PubMed)
- Source type
- Peer reviewed
- Registry ID
pubmed-ipamorelin-pharmacology-1998
Source usage
Linked from 7 pages
Compound
Ipamorelin
ComparisonCJC-1295 + Ipamorelin vs Tesamorelin
ComparisonMK-677 vs Ipamorelin
Evidence curationBest Peptides for Growth Hormone Release
GuidePeptide Category Explainers: How Every Compound Class on This Site Is Defined
GuidePeptide Half-Life Reference Table
GuidePeptide Terminology Glossary
Interpretation boundary
What this record can and cannot establish
Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.